John L. Leguyader

Array ( [id] => 3787315 [patent_doc_number] => 05736525 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Complexes of polyadenylic acid with polyuridylic acid' [patent_app_type] => 1 [patent_app_number] => 8/816643 [patent_app_country] => US [patent_app_date] => 1997-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2459 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736525.pdf [firstpage_image] =>[orig_patent_app_number] => 816643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3974415 [patent_doc_number] => 05916808 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Antisense oligonucleotides which combat aberrant splicing and methods of using the same' [patent_app_type] => 1 [patent_app_number] => 8/802384 [patent_app_country] => US [patent_app_date] => 1997-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7481 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 174 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/916/05916808.pdf [firstpage_image] =>[orig_patent_app_number] => 802384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795421 [patent_doc_number] => 05780611 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Oligomers which inhibit expression of collagen genes' [patent_app_type] => 1 [patent_app_number] => 8/802547 [patent_app_country] => US [patent_app_date] => 1997-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 14 [patent_no_of_words] => 12478 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780611.pdf [firstpage_image] =>[orig_patent_app_number] => 802547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3850872 [patent_doc_number] => 05767102 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Antisense composition and method for treatment of CMV infection' [patent_app_type] => 1 [patent_app_number] => 8/784498 [patent_app_country] => US [patent_app_date] => 1997-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7124 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/767/05767102.pdf [firstpage_image] =>[orig_patent_app_number] => 784498 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811262 [patent_doc_number] => 05811537 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Antisense oligonucleotides targeted against human immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 8/782980 [patent_app_country] => US [patent_app_date] => 1997-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6596 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811537.pdf [firstpage_image] =>[orig_patent_app_number] => 782980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133205 [patent_doc_number] => 06121230 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Anti-VEGF agents in the treatment of endometriosis' [patent_app_type] => 1 [patent_app_number] => 8/750143 [patent_app_country] => US [patent_app_date] => 1997-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 28 [patent_no_of_words] => 5654 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121230.pdf [firstpage_image] =>[orig_patent_app_number] => 750143 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3925523 [patent_doc_number] => 05877022 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Ribozymes targeted to APO(a) RNA' [patent_app_type] => 1 [patent_app_number] => 8/774310 [patent_app_country] => US [patent_app_date] => 1996-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 20993 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877022.pdf [firstpage_image] =>[orig_patent_app_number] => 774310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4044644 [patent_doc_number] => 05869253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-09 [patent_title] => 'Method and reagent for inhibiting hepatitis C virus replication' [patent_app_type] => 1 [patent_app_number] => 8/774306 [patent_app_country] => US [patent_app_date] => 1996-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29132 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/869/05869253.pdf [firstpage_image] =>[orig_patent_app_number] => 774306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105436 [patent_doc_number] => 06022705 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Insect sodium channels gene from insecticide-susceptible and insecticide-resistant house flies' [patent_app_type] => 1 [patent_app_number] => 8/772512 [patent_app_country] => US [patent_app_date] => 1996-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 4 [patent_no_of_words] => 21930 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022705.pdf [firstpage_image] =>[orig_patent_app_number] => 772512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3743924 [patent_doc_number] => 05801158 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Enzymatic RNA with activity to RAS' [patent_app_type] => 1 [patent_app_number] => 8/777918 [patent_app_country] => US [patent_app_date] => 1996-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9249 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801158.pdf [firstpage_image] =>[orig_patent_app_number] => 777918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771253 [patent_doc_number] => 05807743 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-15 [patent_title] => 'Interleukin-2 receptor gamma-chain ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/758306 [patent_app_country] => US [patent_app_date] => 1996-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 73351 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/807/05807743.pdf [firstpage_image] =>[orig_patent_app_number] => 758306 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3783916 [patent_doc_number] => 05840481 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Parasite-derived resistance' [patent_app_type] => 1 [patent_app_number] => 8/758561 [patent_app_country] => US [patent_app_date] => 1996-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11823 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840481.pdf [firstpage_image] =>[orig_patent_app_number] => 758561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3767020 [patent_doc_number] => 05849503 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Mutant proteins of human DNA topoisomerase I' [patent_app_type] => 1 [patent_app_number] => 8/663112 [patent_app_country] => US [patent_app_date] => 1996-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6504 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849503.pdf [firstpage_image] =>[orig_patent_app_number] => 663112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773210 [patent_doc_number] => 05849902 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Three component chimeric antisense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/754580 [patent_app_country] => US [patent_app_date] => 1996-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4434 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849902.pdf [firstpage_image] =>[orig_patent_app_number] => 754580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3829109 [patent_doc_number] => 05739119 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-14 [patent_title] => 'Antisense oligonucleotides specific for the muscarinic type 2 acetylcholine receptor MRNA' [patent_app_type] => 1 [patent_app_number] => 8/749589 [patent_app_country] => US [patent_app_date] => 1996-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7416 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/739/05739119.pdf [firstpage_image] =>[orig_patent_app_number] => 749589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3830444 [patent_doc_number] => 05760181 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-02 [patent_title] => 'Endotoxins' [patent_app_type] => 1 [patent_app_number] => 8/744532 [patent_app_country] => US [patent_app_date] => 1996-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 64 [patent_no_of_words] => 30434 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/760/05760181.pdf [firstpage_image] =>[orig_patent_app_number] => 744532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3988975 [patent_doc_number] => 05910583 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-08 [patent_title] => 'Antisense oligonucleotides against ERBB-2' [patent_app_type] => 1 [patent_app_number] => 8/740821 [patent_app_country] => US [patent_app_date] => 1996-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5807 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/910/05910583.pdf [firstpage_image] =>[orig_patent_app_number] => 740821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4045801 [patent_doc_number] => 05874566 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'Il-15 triplex oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/740215 [patent_app_country] => US [patent_app_date] => 1996-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2328 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874566.pdf [firstpage_image] =>[orig_patent_app_number] => 740215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3865615 [patent_doc_number] => 05837463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Nucleic acid of C type hepatitis virus derivation and process for detection virus using said nucleic acid' [patent_app_type] => 1 [patent_app_number] => 8/731272 [patent_app_country] => US [patent_app_date] => 1996-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 7370 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837463.pdf [firstpage_image] =>[orig_patent_app_number] => 731272 [rel_patent_id] =>[rel_patent_doc_number] =>)